EPISODE · Feb 11, 2022 · 10 MIN
The FDA on Monoclonal Antibody Therapeutics: What physicians need to know, Part I
from AMA Update · host American Medical Association
AMA president Gerald Harmon, MD, welcomes experts from the U.S. Food and Drug Administration (FDA) to discuss what prescribers need to know about COVID-19 therapeutic drugs, Paxlovid and Molnupiravir. Alternative treatment options for high-risk outpatients with mild-moderate COVID-19 are also discussed. Guest: John Farley, MD, MPH, director, Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA
What this episode covers
AMA president Gerald Harmon, MD, welcomes experts from the U.S. Food and Drug Administration (FDA) to discuss what prescribers need to know about COVID-19 therapeutic drugs, Paxlovid and Molnupiravir. Alternative treatment options for high-risk outpatients with mild-moderate COVID-19 are also discussed. Guest: John Farley, MD, MPH, director, Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA
NOW PLAYING
The FDA on Monoclonal Antibody Therapeutics: What physicians need to know, Part I
No transcript for this episode yet
Similar Episodes
Jun 9, 2026 ·3m
Jun 9, 2026 ·4m
Jun 9, 2026 ·3m
Jun 8, 2026 ·3m
Jun 8, 2026 ·3m
Jun 8, 2026 ·40m